Latest Health News

Ambertech Limited anticipates surpassing $100 million in revenue for FY25, driven by a strong second half and improved profitability across key segments.

Gratifii Limited has posted a record $19.4 million in cash receipts for 4Q FY25, marking a 210% year-on-year increase and signaling strong momentum as it nears completion of its platform migration and expands its Member’s Mobile offering.

Singular Health has landed a pivotal $2 million US pilot contract with Provider Network Solutions and completed an $8 million capital raise, advancing its medical imaging platform’s regulatory and product development milestones.

GreenX Metals advances its German and Greenland projects with modern exploration techniques and secures a significant arbitration award against Poland, positioning itself strongly in critical minerals markets.

Oneview Healthcare reported a €4 million cash outflow in Q2 2025, driven by restructuring and lower R&D credits, while securing new US hospital contracts and expanding AI-powered care solutions.

Nuchev Limited reports a record-breaking Q4 FY25 with revenues soaring 167% year-on-year, driven by strong growth across multiple markets and a strategic agency agreement in Australia.

Corella Resources has successfully raised over $1 million through a Rights Issue and Placement, positioning itself to advance exploration and development at its Tampu Project and other tenements.

Catalyst Metals reported steady gold production in the June 2025 quarter, progressing development at its Trident project while completing key corporate transactions that strengthen its growth outlook.

Step One Clothing reports modest revenue growth for FY25 despite a dip in earnings before interest and tax, highlighting ongoing consumer caution and strategic marketing restraint.

Alcidion Group Limited has reported its strongest quarter ever with record operating cashflow and a doubling of new sales, reaffirming its positive outlook for FY25.

QuickFee Limited reports a record A$7.2 million quarterly revenue, driven by strong US and Australian growth, alongside positive underlying profitability and a major refinancing.

Audeara Ltd has reported a landmark FY25 with record cash receipts of $4.9 million, driven by strong domestic sales and expanding global technology partnerships. The company’s strategic R&D and inventory build set the stage for further growth in FY26.